Clin2
NCT07224386Possibly a fitNot yet recruiting

Monitoring Myasthenia Gravis Symptoms with Wearable Sensors

Myasthenia GravisMyasthenia Gravis, Generalized

Part of Brain & nervous system, Cancer, Immune system & allergy clinical trials.

This study uses wearable sensors and smartphone apps to track your myasthenia gravis symptoms over time. It aims to see how well these technologies can measure your condition in daily life, which could help you and your doctor manage your care better.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 80 years
Study type
Observational

Who can take part

  • You have been diagnosed with autoimmune myasthenia gravis (MG) — not another type of muscle weakness.
  • Your MG severity is class II, III, or IV (moderate to severe, but not crisis).
  • You have had a positive antibody test (AChR, MuSK, or LRP4) or an abnormal nerve-to-muscle signal test (like single-fiber EMG).
  • You can walk 10 meters (about 33 feet) on your own, with or without a walker or cane.
  • You are between 18 and 80 years old and speak English fluently.
  • You are not currently in a nursing home, hospice, or prison, and you are not pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07226830Not yet recruiting
Tracking MG symptoms after starting VYVGART

This study uses a smartphone app (BioDigit MG) to monitor how your myasthenia gravis symptoms change after you start treatment with VYVGART or VYVGART Hytrulo. It aims to see if the app can reliably measure disease activity.

Boston, Massachusetts
NCT07761026Recruiting
Living with myasthenia gravis: share your experience

This 10-year study collects information from people with myasthenia gravis to learn more about the condition and improve care. By sharing your experiences, you can help researchers understand what daily life is like and shape future treatments.

Framingham, Massachusetts
NCT07323316Not yet recruiting
Remote monitoring of myasthenia gravis using MyoSense 360 app

This trial uses a smartphone app and an activity tracker to remotely monitor symptoms of generalized myasthenia gravis (gMG). It aims to improve how doctors track your condition from home.

NCT05564936Recruiting
Digital tests for generalized myasthenia gravis using a smartphone

This study tests a smartphone-based digital tool that helps check symptoms in people with generalized myasthenia gravis (MG). It may help patients and clinicians track how the disease is doing over time using simpler, repeated assessments.

Aurora, Colorado
NCT06743490Recruiting
Tracking MG symptoms with smartphone recordings

This study uses your smartphone to record symptoms like slurred speech, hoarseness, arm fatigue, or droopy eyelids, making it easier for doctors to understand and monitor myasthenia gravis. Both people with MG and healthy volunteers can take part.

Leiden, South Holland
NCT07146425Recruiting
Building a digital assessment model for myasthenia gravis

This study uses digital tools like questionnaires and smartphone tests to measure how myasthenia gravis affects you. It aims to create a better way for doctors to track your symptoms and adjust treatment.

Shanghai

Hear when a new Myasthenia Gravis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.